MedTrace Logo

High-frequency SCS in Treatment of Chronic Limb-Threatening Ischemia

NCT05322798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-04-12

No results posted yet for this study

Summary

The study of high-frequency spinal cord stimulation (SCS) efficacy in the treatment of chronic limb-threatening ischemia (CLTI)

Conditions

  • Chronic Limb-Threatening Ischemia

Interventions

PROCEDURE

High-frequency SCS

Continous high-frequency stimulation (frequency - 1kHz, pulse width - 30 µs).

PROCEDURE

Low-frequency SCS

Continuous conventional stimulation (frequency - 30-60 Hz, pulse width - 250-500 µs).

Sponsors & Collaborators

  • Meshalkin Research Institute of Pathology of Circulation

    lead NETWORK

Principal Investigators

  • Kiril Orlov, MD, PhD · Meshalkin National Medical Research Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-12
Primary Completion
2020-05-30
Completion
2021-05-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05322798 on ClinicalTrials.gov